n-(4-cyanophenyl)glycine,
42288-26-6,
2-((4-Cyanophenyl)amino)acetic acid,
2-(4-Cyanophenylamino)acetic acid,
N-(4-CYANO-PHENYL)-GLYCINE,
2-[(4-cyanophenyl)amino]acetic Acid,
N-(4-cyanophenyl)-Glycine,
2-(4-cyanoanilino)acetic acid,
[(4-cyanophenyl)amino]acetic acid,
Glycine, N-(4-cyanophenyl)-,
AC1LGAAU,
(4-cyanophenyl)glycine,
4-cyano-phenylglycine;,
4-cyanophenyl-glycine;,
PubChem18108,
N-4-cyanophenylglycine;,
N-(p-cyanophenyl)-glycine,
AC1Q4RG2,
N-(4-cyanophenyl)glycine;,
4-cyanophenylaminoacetic acid,
Oprea1_114543,
KSC235A9F,
SCHEMBL361315,
4-cyanophenylaminoacetic acid;,
DL-4-CYANOPHENYLGLYCINE,
AC1Q761M,
CTK1D5092,
KS-00000ABC,
(4-cyano-phenylamino)acetic acid,
DTXSID80355883,
KJRQMXRCZULRHF-UHFFFAOYSA-N,
(4-cyano-phenylamino)acetic acid;,
ZINC332337,
(4-Cyano-phenylamino)-acetic acid,
BCP04527,
CS-D0913,
2-(4-cyanophenylamino) acetic acid,
ANW-50338,
EBD217740,
MFCD01464022,
RW2419,
SBB064242,
SC3501,
AKOS000218605,
AC-7903,
ACN-025211,
AN-8550,
FS-3199,
LS40290,
MCULE-6156960439,
RL03630,
RTR-016585,
TRA0098072,
AJ-19529,
AK-49065,
BC224366,
BR-49065,
SC-44574,
SY021403,
AB0028924,
DB-003865,
TR-016585,
AM20090750,
BB 0253985,
FT-0647115,
ST24032316,
X1037,
EN300-52080,
S-1780,
MFCD01464022 (97+%),
288C266,
I01-4436,
Q-102527,
C9H8N2O2,
2-(4-cyanophenylamino)aceticacid,
AR-1J9135,
CID817965,
CB11792,
C2771,
Dabigatran intermediate;Glycine, N-(4-cyanophenyl)-,
253797-03-4,
42772-82-7,
769195-26-8,